Transferrin receptor 1 upregulation in primary tumor and downregulation in benign kidney is associated with progression and mortality in renal cell carcinoma patientsChristopher Greene, Eric Kauffman|Oncotarget|2017Cited by 88
Preclinical efficacy of dual mTORC1/2 inhibitor AZD8055 in renal cell carcinoma harboring a TFE3 gene fusionEric Kauffman, Ramaprasad Srinivasan|BMC Cancer|2019Cited by 30
Suppressive effects of iron chelation in clear cell renal cell carcinoma and their dependency on VHL inactivationChristopher Greene, Eric Kauffman|Free Radical Biology and Medicine|2018Cited by 22